216 related articles for article (PubMed ID: 20385104)
21. Taxol-induced ceramide generation and apoptosis in human breast cancer cells.
Charles AG; Han TY; Liu YY; Hansen N; Giuliano AE; Cabot MC
Cancer Chemother Pharmacol; 2001 May; 47(5):444-50. PubMed ID: 11391861
[TBL] [Abstract][Full Text] [Related]
22. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function.
Sultan I; Senkal CE; Ponnusamy S; Bielawski J; Szulc Z; Bielawska A; Hannun YA; Ogretmen B
Biochem J; 2006 Jan; 393(Pt 2):513-21. PubMed ID: 16201965
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis occurs via the ceramide recycling pathway in human HaCaT keratinocytes.
Takeda S; Mitsutake S; Tsuji K; Igarashi Y
J Biochem; 2006 Feb; 139(2):255-62. PubMed ID: 16452313
[TBL] [Abstract][Full Text] [Related]
25. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
Stover TC; Sharma A; Robertson GP; Kester M
Clin Cancer Res; 2005 May; 11(9):3465-74. PubMed ID: 15867249
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phosphatidylcholine and phosphatidylethanolamine biosynthesis in rat-2 fibroblasts by cell-permeable ceramides.
Bladergroen BA; Bussière M; Klein W; Geelen MJ; Van Golde LM; Houweling M
Eur J Biochem; 1999 Aug; 264(1):152-60. PubMed ID: 10447683
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of rat sympathetic neuron apoptosis by ceramide. Role of p75NTR in ceramide generation.
Song MS; Posse de Chaves EI
Neuropharmacology; 2003 Dec; 45(8):1130-50. PubMed ID: 14614956
[TBL] [Abstract][Full Text] [Related]
29. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.
Allan D
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519
[TBL] [Abstract][Full Text] [Related]
30. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
[TBL] [Abstract][Full Text] [Related]
31. A hypothetical proposal to employ meperidine and tamoxifen in treatment of glioblastoma. Role of P-glycoprotein, ceramide and metabolic pathways.
Altinoz MA; Ozpinar A; Hacker E; Ozpinar A
Clin Neurol Neurosurg; 2022 Apr; 215():107208. PubMed ID: 35316699
[TBL] [Abstract][Full Text] [Related]
32. Commitment to apoptosis by ceramides depends on mitochondrial respiratory function, cytochrome c release and caspase-3 activation in Hep-G2 cells.
Gentil B; Grimot F; Riva C
Mol Cell Biochem; 2003 Dec; 254(1-2):203-10. PubMed ID: 14674699
[TBL] [Abstract][Full Text] [Related]
33. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
[TBL] [Abstract][Full Text] [Related]
34. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth.
Hartmann D; Lucks J; Fuchs S; Schiffmann S; Schreiber Y; Ferreirós N; Merkens J; Marschalek R; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2012 Apr; 44(4):620-8. PubMed ID: 22230369
[TBL] [Abstract][Full Text] [Related]
35. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
36. Trafficking of Acetyl-C16-Ceramide-NBD with Long-Term Stability and No Cytotoxicity into the Golgi Complex.
Makiyama T; Nakamura H; Nagasaka N; Yamashita H; Honda T; Yamaguchi N; Nishida A; Murayama T
Traffic; 2015 May; 16(5):476-92. PubMed ID: 25615589
[TBL] [Abstract][Full Text] [Related]
37. Brefeldin A limits N-hexanoylsphingosine-induced accumulation of natural ceramide via the salvage pathway by enhancing glucosylation.
Spinedi A
Lipids; 2014 Feb; 49(2):207-10. PubMed ID: 24194457
[TBL] [Abstract][Full Text] [Related]
38. Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
Morad SAF; MacDougall MR; Abdelmageed N; Kao LP; Feith DJ; Tan SF; Kester M; Loughran TP; Wang HG; Cabot MC
Exp Cell Res; 2019 Aug; 381(2):256-264. PubMed ID: 31112736
[TBL] [Abstract][Full Text] [Related]
39. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
Liu YY; Hill RA; Li YT
Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species.
Chan SY; Hilchie AL; Brown MG; Anderson R; Hoskin DW
Exp Mol Pathol; 2007 Feb; 82(1):1-11. PubMed ID: 16624283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
